
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Date: March 04 - March 04, 2015
Description:
Event type: CE
Event Address: Dennis Wicker Civic Center
Sponsor: North Carolina Academy of Small Animal Medicine / NCASAM
For More Information:melissa Autry, North Carolina Academy of Small Animal Medicine / NCASAM
910-452-3899, [email protected]





